Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan

被引:30
|
作者
Hsu, Ching-Sheng [1 ,2 ,3 ,4 ]
Kao, Jia-Horng [1 ,4 ,5 ,6 ,7 ]
机构
[1] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10002, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei Branch, Taipei, Taiwan
[3] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10002, Taiwan
[6] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10002, Taiwan
[7] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10002, Taiwan
关键词
fatty liver; hepatitis B virus; hepatitis C virus; metabolic syndrome; NASH; Taiwan; ASIA-PACIFIC REGION; CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIPID-PEROXIDATION; ADULT-POPULATION; DIAGNOSTIC-VALUE; CHINESE PATIENTS;
D O I
10.1016/j.jfma.2012.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, and has become increasingly recognized as a public health problem in Taiwan. Patients with non-alcoholic steatohepatitis, a more severe form of NAFLD, may progress to cirrhosis and its related complications, including hepatocellular carcinoma. Since NAFLD is highly linked to metabolic syndrome, such patients may have increased risks of complications related to both liver disease and metabolic syndrome. Therefore, if we fail to cope with this growing health problem, NAFLD may gradually replace viral hepatitis as the major etiology of liver disease in Taiwan. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 50 条
  • [31] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [32] Liver transplantation for non-alcoholic fatty liver disease
    Germani, Giacomo
    Becchetti, Chiara
    [J]. MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (02) : 138 - 146
  • [33] Non-alcoholic fatty liver disease and liver secretome
    Muhammad Sohaib Khan
    Choongho Lee
    Sang Geon Kim
    [J]. Archives of Pharmacal Research, 2022, 45 : 938 - 963
  • [34] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    [J]. World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [35] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [36] Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis
    Wong, Vincent Wai-Sun
    Singal, Ashwani K.
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [37] Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
    Lin, Ying-Chin
    Chou, Shou-Chu
    Huang, Pai-Tsang
    Chiou, Hung-Yi
    [J]. ANNALS OF HEPATOLOGY, 2011, 10 (02) : 125 - 132
  • [38] Non-Alcoholic Fatty Liver Disease and Disease Mongering
    Braillon, Alain
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07): : E626 - E626
  • [39] Non-alcoholic fatty liver disease and cardiovascular disease
    Santos, Raul D.
    Agewall, Stefan
    [J]. ATHEROSCLEROSIS, 2012, 224 (02) : 324 - 325
  • [40] Coeliac disease and non-alcoholic fatty liver disease
    Marignani, M
    Angeletti, S
    Ruggeri, M
    Cassetta, S
    Delle Fave, G
    [J]. DIGESTIVE AND LIVER DISEASE, 2004, 36 (11) : 781 - 781